Effect of tumor necrosis factor-&alpha; antagonists on oxidative stress in patients with Crohn&rsquo;s disease

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 21, Issue 35

Peer-Review Report of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Clinical Trials Study

World J Gastroenterol. Sep 21, 2015; 21(35): 10208-10214
Published online Sep 21, 2015. doi: 10.3748/wjg.v21.i35.10208

Table 1 Clinical characteristics of patients n (%)

Characteristics	All patients (n = 42)
Sex
Male	30 (71)
Female	12 (29)
Age (yr), median	31.9 (17-57)
Disease duration (yr), median	6.2 (0-16)
Disease type
Ileal	11 (26)
Ileo-colonic	26 (62)
Colonic	5 (12)
Patients with concomitant medication
5-aminosalicylic acid	41 (98)
Prednisone	9 (21)
Azathioprine	7 (17)
Enteral nutrition	24 (57)
Previous segmental resection	8 (19)
Infliximab	10 (24)
Adalimumab	32 (76)

Citation: Yamamoto K, Chiba T, Matsumoto T. Effect of tumor necrosis factor-α antagonists on oxidative stress in patients with Crohn’s disease. World J Gastroenterol 2015; 21(35): 10208-10214
URL: https://www.wjgnet.com/1007-9327/full/v21/i35/10208.htm
DOI: https://dx.doi.org/10.3748/wjg.v21.i35.10208

Yamamoto K, Chiba T, Matsumoto T. Effect of tumor necrosis factor-α antagonists on oxidative stress in patients with Crohn’s disease. World J Gastroenterol 2015; 21(35): 10208-10214 [PMID: 26401086 DOI: 10.3748/wjg.v21.i35.10208]

All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.